PIL seeks ban on manufacture, sale of Nimesulide

CHENNAI SEPT. 26. A public interest litigation petition seeking to ban the manufacture and sale of Nimesulide, a non-steroidal and anti-inflammatory drug, has been filed in the Madras High Court.

The First Bench comprising the Chief Justice, B. Subhashan Reddy, and Justice A. Kulasekaran, admitted the petition filed by the Tamil Nadu Health Development Forum, and ordered notices to the Union Health Secretary and the Drugs Controller-General of India.

The forum secretary and the former Director of the Institute of Child Health at the Government Children's Hospital here, C.S. Rex Sargunam, contended that though it was not an anti-fever drug it can bring down the temperature faster than other anti-fever drugs like paracetamol.

He said the drug could cause severe sideeffects. ``A person does not die of fever and joint pain, but dies of liver or kidney damage caused by the repeated use of Nimesulide''.

According to Dr. Sargunam it was the most expensive non-steroided anti-inflammatory drug and was not under the price control regime of the respondent-authorities.

In developed countries such as the United States, Britain, Canada and Australia, Nimesulide is not approved for use even for adults, whereas Finland, Spain, Turkey, etc., have banned the drug, the petition claimed.

Dr. Sargunam prayed for a direction to ban the manufacture and marketing of Nimesulide.

Recommended for you